The Transcranial Light Therapy Improves Synaptic Plasticity in the Alzheimer’s Disease Mouse Model
Alzheimer’s disease (AD) is the main cause of dementia worldwide. Emerging non-invasive treatments such as photobiomodulation target the mitochondria to minimize brain damage, improving cognitive functions. In this work, an experimental design was carried out to evaluate the effect of transcranial l...
Main Authors: | Débora Buendía, Tatiana Guncay, Macarena Oyanedel, Makarena Lemus, Alejandro Weinstein, Álvaro O. Ardiles, José Marcos, Adriana Fernandes, Renato Zângaro, Pablo Muñoz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/12/10/1272 |
Similar Items
-
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
by: Johanna Nilsson, et al.
Published: (2021-01-01) -
microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
by: Dolores Siedlecki-Wullich, et al.
Published: (2021-01-01) -
Editorial: The Molecular Mechanisms of Synaptic Plasticity Impairments in Alzheimer’s Disease
by: Gong-Ping Liu, et al.
Published: (2022-01-01) -
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
by: Pablo Mohaupt, et al.
Published: (2022-11-01) -
Effect of exercise on cognitive function and synaptic plasticity in Alzheimer's disease models: A systematic review and meta-analysis
by: Linlin Guo, et al.
Published: (2023-01-01)